Brief: New Enterprise Associates 14 Reports 6.3% Stake In Lumos Pharma- SEC Filing
01/04/2020 13:03
April 1 (Reuters) - Lumos Pharma Inc LUMO.O :
* NEW ENTERPRISE ASSOCIATES 14 LP REPORTS 6.3% STAKE IN
LUMOS
PHARMA INC AS OF MARCH 18 - SEC FILING
Source : (https://bit.ly/2WXOw5i)
Further company coverage: LUMO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lumos Pharma
See all newsLumos Pharma Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow
U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla
Lumos Pharma climbs on $38 mln go-private deal
Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)